Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism. 1997

H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
Department of Hypertension and Angiology, Academy of Medicine, Warsaw, Poland.

The plasma aldosterone to renin activity ratio (A/PRA) was assessed retrospectively in 103 patients with primary aldosteronism including 74 patients with surgically proven adrenal cortical adenoma (APA) and 29 patients with idiopathic adrenal cortical hyperplasia (IHA). The results were compared with those obtained in 31 patients with essential hypertension (EH) and 45 healthy normotensive controls. The upper limit of normal A/PRA ratio, as obtained in the controls was 17.8. This value was exceeded in 89% of patients with APA; postoperatively it decreased in 97% of the APA group, and returned to normal in 81%. In the IHA group the A/PRA was elevated in 70% of patients. The normal ratios in patients with primary aldosteronism were associated with unsuppressed plasma renin activity (PRA). Although the mean values of the A/PRA ratio differed significantly between the groups, complete separation was not obtained. The serum potassium level at time of testing did not influence the diagnostic value of the A/PRA ratio, although an inverse correlation between serum potassium and the A/PRA ratio was found in the patients with APA. This study supports the high sensitivity of the A/PRA ratio in diagnosis of primary aldosteronism, however, a single determination with a normal result may not be sufficient for exclusion of the disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer

Related Publications

H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
December 1986, Acta endocrinologica,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
February 2004, Journal of hypertension,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
December 2002, Hypertension (Dallas, Tex. : 1979),
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
November 1982, Archives of internal medicine,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
May 2008, Journal of hypertension,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
October 2006, Zhonghua xin xue guan bing za zhi,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
January 2024, Diabetes, metabolic syndrome and obesity : targets and therapy,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
December 2022, The Journal of clinical endocrinology and metabolism,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
November 2022, Journal of hypertension,
H Ignatowska-Switalska, and J Chodakowska, and W Januszewicz, and T Feltynowski, and M Adamczyk, and J Lewandowski
February 2002, Mayo Clinic proceedings,
Copied contents to your clipboard!